Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands
Autor: | Anneke J. van der Kooi, Benno Küsters, Catharina G. Faber, Corien C. Verschuuren-Bemelmans, Corrie E. Erasmus, Nicol C. Voermans, Baziel G.M. van Engelen, Erik-Jan Kamsteeg, Heinz Jungbluth, Floor A. M. Duijkers, Bregje Jaeger, Meyke Schouten, Stacha F. I. Reumers, Karlijn Bouman, Maartje Pennings |
---|---|
Přispěvatelé: | Pediatric surgery, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, Klinische Neurowetenschappen, MUMC+: MA Med Staf Spec Neurologie (9), Human Genetics, Neurology, ANS - Neuroinfection & -inflammation, Paediatric Neurology, EURO-NMD |
Rok vydání: | 2021 |
Předmět: |
Male
Pathology BIN1 Biopsy Sensory disorders Donders Center for Medical Neuroscience [Radboudumc 12] centronuclear myopathy Genes X-Linked RYR1 Medicine Age of Onset Child Genetics (clinical) Netherlands Aged 80 and over medicine.diagnostic_test Histocytochemistry CONGENITAL MYOPATHIES Incidence cohort Middle Aged Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3] Hypotonia Phenotype Child Preschool Female medicine.symptom Myopathies Structural Congenital Adult medicine.medical_specialty MTM1 Adolescent Genotype MYOTONIC-DYSTROPHY DISORDERS MYOTUBULAR MYOPATHY Other Research Donders Center for Medical Neuroscience [Radboudumc 0] DYNAMIN 2 Exercise intolerance FREQUENCY Young Adult Genetics Humans Genetic Predisposition to Disease Centronuclear myopathy Alleles Genetic Association Studies Aged Muscle biopsy business.industry Genetic heterogeneity MUTATIONS Infant Newborn Infant Muscle weakness DNM2 medicine.disease Congenital myopathy Cross-Sectional Studies Amino Acid Substitution Mutation business Biomarkers |
Zdroj: | Clinical Genetics, 100(6), 692-702. Wiley Clinical Genetics, 100, 6, pp. 692-702 Clinical Genetics, 100(6), 692-702. Wiley-Blackwell Clinical genetics, 100(6), 692-702. Wiley-Blackwell Clinical Genetics, 100, 692-702 Reumers, S F I, Erasmus, C E, Bouman, K, Pennings, M, Schouten, M, Kusters, B, Duijkers, F A M, van der Kooi, A, Jaeger, B, Verschuuren-Bemelmans, C C, Faber, C G, van Engelen, B G, Kamsteeg, E J, Jungbluth, H & Voermans, N C 2021, ' Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands ', Clinical Genetics, vol. 100, no. 6, pp. 692-702 . https://doi.org/10.1111/cge.14054 |
ISSN: | 0009-9163 |
DOI: | 10.1111/cge.14054 |
Popis: | Contains fulltext : 241356.pdf (Publisher’s version ) (Open Access) Centronuclear myopathy (CNM) is a genetically heterogeneous congenital myopathy characterized by muscle weakness, atrophy, and variable degrees of cardiorespiratory involvement. The clinical severity is largely explained by genotype (DNM2, MTM1, RYR1, BIN1, TTN, and other rarer genetic backgrounds), specific mutation(s), and age of the patient. The histopathological hallmark of CNM is the presence of internal centralized nuclei on muscle biopsy. Information on the phenotypical spectrum, subtype prevalence, and phenotype-genotype correlations is limited. To characterize CNM more comprehensively, we retrospectively assessed a national cohort of 48 CNM patients (mean age = 32 ± 24 years, range 0-80, 54% males) from the Netherlands clinically, histologically, and genetically. All information was extracted from entries in the patient's medical records, between 2000 and 2020. Frequent clinical features in addition to muscle weakness and hypotonia were fatigue and exercise intolerance in more mildly affected cases. Genetic analysis showed variants in four genes (18 DNM2, 14 MTM1, 9 RYR1, and 7 BIN1), including 16 novel variants. In addition to central nuclei, histologic examination revealed a large variability of myopathic features in the different genotypes. The identification and characterization of these patients contribute to trial readiness. |
Databáze: | OpenAIRE |
Externí odkaz: |